Profs Vince and More featured on KSTP-5 Eyewitness News
Camera at U of M may help researchers detect early signs of Alzheimer's. For the news report by Ellen Galles and to watch the video: Click Here
Photo by Susan Kirby-Smith
Prof Christine Salomon's lecture brings large crowd
CDD signs a licensing agreement for its technology for early detection of Alzheimer's disease
Center for Drug Design (College of Pharmacy, University of Minnesota) has signed an agreement to collaborate with medical imaging startup RetiSpec to commercialize the technology for early detection of Alzheimer’s disease. Read More
Photo by Greta Kaul
Patently lucrative: the intellectual property that makes big money for the U
Compounds developed in Robert Vince’s University of Minnesota lab to combat the HIV virus made the University more than $600 million dollars. Read More
Message from the Director
The Center for Drug Design (CDD) was created to combine research and scholarship leading to the development of novel drugs for therapeutic applications, such as HIV, cancer, neurological diseases, dermatological agents, infectious diseases, novel processes, and medical devices. The Center for Drug Design combines the best of academic tradition along with an expectation of innovation and independence, and provides significant value for our academic and research community.
Raymond F. Schinazi, PhD, DSc
Director, Laboratory of Biochemical Pharmacology (LOBP)
Director, Scientific Working Group on Viral Eradication, Emory University Center for AIDS Research
The LOBP has established standardized protocols to evaluate novel compounds for their antiviral potency for a variety of human viruses and toxicity profiles using a panel of target cells. In addition, Schinazi labs also assay for selection of drug-resistance.